サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1622903

腹膜透析の世界市場：治療タイプ別、製品タイプ別、エンドユーザー別、地域別、範囲および予測

Global Peritoneal Dialysis Market By Treatment Type (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), By Product Type, By End User, By Geographic Scope and Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
腹膜透析の世界市場：治療タイプ別、製品タイプ別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年08月31日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腹膜透析の世界市場規模・予測

腹膜透析の世界市場規模は、2024年に854億1,000万米ドルと評価され、2024年～2031年の間に7.30％のCAGRで成長する見込みで、2031年には1,500億8,000万米ドルに達すると予測されています。腹膜透析は、腹腔を覆う膜である腹膜を天然のフィルターとして利用し、血液中の老廃物や余分な水分を除去する腎代替療法です。この方法では、無菌の透析液を腹腔内に注入し、腹膜を通して老廃物を吸収させた後、排出します。

腹膜透析は、慢性腎臓病や腎移植を待つ患者に広く用いられており、在宅治療、生活の質の向上、ライフスタイルの柔軟性などの利点があります。

腹膜透析の将来は有望であり、患者の治療成績の向上、体液と溶質の除去効率の向上、合併症の減少を目的とした技術とソリューションの進歩が見込まれています。

腹膜透析の世界市場力学

世界の腹膜透析市場を形成している主な市場力学

主な市場促進要因

慢性腎臓病（CKD）の有病率の上昇：

慢性腎臓病（CKD）の有病率の上昇：慢性腎臓病の罹患率の増加は、透析治療の需要を大きく牽引しています。米国疾病予防管理センター（CDC）によると、米国では約3,700万人の成人がCKDに罹患していると推定され、そのかなりの割合が透析を必要としています。

高齢化の進展：

高齢化は腹膜透析市場の拡大にとって重要な要素です。世界保健機関（WHO）は、60歳以上の世界人口が2050年までに20億人に達すると予測しており、腎臓関連疾患の有病率と透析オプションの必要性が高まると予想されています。

在宅医療へのシフト：

在宅透析は患者に利便性と自律性を提供することから、注目すべき動向となっています。米国腎データシステム（USRDS）の報告によると、2020年時点で、米国の透析患者の約8％が腹膜透析を利用しており、在宅療法への嗜好が高まっていることを反映しています。

技術の進歩：

腹膜透析機器やソリューションの革新は、治療効率と患者の転帰を向上させています。国際腹膜透析学会（International Society for Peritoneal Dialysis）の報告によると、新しい自動化システムや改良された透析ソリューションは、患者の受容性と満足度を高め、市場成長を促進する可能性があります。2022年の腹膜透析市場規模は45億米ドルで、2030年までの年間平均成長率（CAGR）は6.5%と予測されています。

主な課題

感染リスク：腹膜透析は感染症、特に腹膜炎のリスクが高く、治療を複雑にし、深刻な健康問題につながる可能性があります。このようなリスクは、患者が血液透析よりも腹膜透析を選択することを躊躇させる可能性があります。

患者教育とトレーニング：腹膜透析を効果的に行うには、在宅治療を成功させるための適切な患者教育とトレーニングが必要です。多くの患者は、必要な技術を習得するために必要な支援やリソースが不足している可能性があり、これがコンプライアンスや治療成績に影響を及ぼす可能性があります。

アクセスと経済性：腹膜透析へのアクセスは、特定の地域、特に低所得者や農村部では制限されることがあります。さらに、機器、消耗品、ヘルスケアサービスに関連する高額な費用が、この治療を求める患者にとって障壁となる可能性があります。

心理社会的要因：不安、抑うつ、社会的孤立などの心理的側面は、患者の在宅透析への意欲に影響を与える可能性があります。このような心理社会的課題に対処することは、治療アドヒアランスとQOLの向上に不可欠です。

主な動向

デジタルヘルス技術の統合：遠隔医療や遠隔モニタリング技術の導入は、腹膜透析における患者管理とフォローアップケアを強化しています。これらの技術革新により、治療プロトコルの遵守率が向上し、タイムリーな介入が可能になるため、患者の転帰が改善されます。

個別化治療アプローチ：腹膜透析では、個々の患者のニーズに合わせて治療計画を立てる個別化医療の傾向が強まっています。これには、患者固有のパラメータに基づいて透析液やスケジュールを調整することが含まれ、これにより有効性と満足度が向上します。

患者教育プログラムの拡大：患者とヘルスケアプロバイダーの双方を対象とした教育プログラムの充実が一般的になってきています。このようなプログラムは、腹膜透析の手順、合併症の可能性、管理戦略について患者を教育することに重点を置いており、コンプライアンスと治療成績の向上につながります。

研究開発の増加：腹膜透析液や腹膜透析装置を改善するための継続的な研究が優先されています。企業は、腹膜透析の効率と安全性を高めるために、生体適合性のある新しい腹膜透析液や自動化システムの開発に投資しており、今後数年のうちに有望な製品が市場に投入される見込みです。

目次

第1章 世界の腹膜透析市場のイントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の腹膜透析市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 腹膜透析の世界市場：治療タイプ別

  • 概要
  • 持続携行式腹膜透析（CAPD）
  • 自動腹膜透析（APD）

第6章 腹膜透析の世界市場：製品タイプ別

  • 概要
  • 腹膜透析液
  • 腹膜透析デバイス
  • 腹膜透析セット
  • カテーテル
  • その他

第7章 腹膜透析の世界市場：エンドユーザー別

  • 概要
  • 在宅透析
  • 透析センターおよび病院ベースの透析

第8章 腹膜透析の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 世界の腹膜透析市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展戦略

第10章 企業プロファイル

  • Baxter International Inc.
  • Fresenius Medical Care
  • NxStage Medical Inc.
  • DaVita Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Nipro Corporation
  • B. Braun Melsungen AG
  • Minntech Corporation
  • Maruho Co., Ltd.
  • Terumo Corporation

第11章 主な発展

  • 製品上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 5350

Global Peritoneal Dialysis Market Size and Forecast

Global Peritoneal Dialysis Market size was valued at USD 85.41 Billion in 2024 and is projected to reach USD 150.08 Billion by 2031 , growing at a CAGR of 7.30% from 2024 to 2031. Peritoneal Dialysis is a renal replacement therapy that utilizes the peritoneum, a membrane lining the abdominal cavity, as a natural filter to remove waste products and excess fluids from the bloodstream. This method involves the infusion of a sterile dialysis solution into the abdominal cavity, where it absorbs waste through the peritoneal membrane and is then drained out.

Widely used for patients with chronic kidney disease or those awaiting kidney transplantation, peritoneal dialysis offers the advantages of home-based treatment, improved quality of life, and flexibility in lifestyle.

The future of peritoneal dialysis looks promising, with advancements in technology and solutions aimed at enhancing patient outcomes, increasing the efficiency of fluid and solute removal, and reducing complications.

Global Peritoneal Dialysis Market Dynamics

The key market dynamics that are shaping the global peritoneal dialysis market include:

Key Market Drivers:

Rising Prevalence of Chronic Kidney Disease (CKD):

The increasing incidence of chronic kidney disease significantly drives the demand for dialysis treatments. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a significant proportion requiring dialysis.

Growing Aging Population:

The aging population is a critical factor in the expansion of the peritoneal dialysis market. The World Health Organization (WHO) projects that the global population aged 60 years and older will reach 2 billion by 2050, which is expected to increase the prevalence of kidney-related diseases and the need for dialysis options.

Shift Toward Home-Based Care:

There is a notable trend toward home-based dialysis solutions due to the convenience and autonomy they offer patients. According to a report from the United States Renal Data System (USRDS), as of 2020, approximately 8% of all dialysis patients in the U.S. were using peritoneal dialysis, reflecting a growing preference for home therapies.

Technological Advancements:

Innovations in peritoneal dialysis equipment and solutions are enhancing treatment efficiency and patient outcomes. The International Society for Peritoneal Dialysis reported that new automated systems and improved dialysis solutions have the potential to increase patient acceptance and satisfaction, driving market growth. In 2022, the peritoneal dialysis market was valued at $4.5 billion and is projected to grow at a compound annual growth rate (CAGR) of 6.5% through 2030.

Key Challenges:

Infection Risks: Peritoneal dialysis is associated with a higher risk of infections, particularly peritonitis, which can complicate treatment and lead to severe health issues. This risk can deter patients from choosing this modality over hemodialysis.

Patient Education and Training: Effective peritoneal dialysis requires proper patient education and training to ensure successful home-based treatment. Many patients may lack the necessary support or resources to learn the required techniques, which can affect compliance and outcomes.

Access and Affordability: Access to peritoneal dialysis can be limited in certain regions, particularly in low-income or rural areas. Additionally, high costs associated with equipment, supplies, and healthcare services can pose a barrier for patients seeking this treatment.

Psychosocial Factors: Psychological aspects such as anxiety, depression, and social isolation can impact patients' willingness to engage in home dialysis. Addressing these psychosocial challenges is essential for improving treatment adherence and quality of life.

Key Trends:

Integration of Digital Health Technologies: The incorporation of telehealth and remote monitoring technologies is enhancing patient management and follow-up care in peritoneal dialysis. These innovations allow for better adherence to treatment protocols and timely intervention, thereby improving patient outcomes.

Personalized Treatment Approaches: There is a growing trend toward personalized medicine in peritoneal dialysis, where treatment plans are tailored to individual patient needs. This includes adjusting dialysis solutions and schedules based on patient-specific parameters, which can improve efficacy and satisfaction.

Expansion of Patient Education Programs: Enhanced educational initiatives aimed at both patients and healthcare providers are becoming more common. These programs focus on training patients about peritoneal dialysis procedures, potential complications, and management strategies, leading to better compliance and outcomes.

Increased Research and Development: Ongoing research efforts to improve peritoneal dialysis solutions and equipment are being prioritized. Companies are investing in developing new biocompatible solutions and automated systems to enhance the efficiency and safety of peritoneal dialysis, with several promising products expected to enter the market in the coming years.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Peritoneal Dialysis Market Regional Analysis

Here is a more detailed regional analysis of the global peritoneal dialysis market:

North America:

North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a substantial proportion requiring dialysis treatment, driving the demand for peritoneal dialysis.

The presence of key market players, such as Baxter International and Fresenius Medical Care, further strengthens North America's leading position in the peritoneal dialysis market. In 2023, the North American market for peritoneal dialysis was valued at approximately $1.2 billion, reflecting a robust growth trajectory fueled by technological advancements and increased patient education regarding home-based treatment options.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases. According to the National Kidney Foundation, the prevalence of kidney disease in India is expected to reach 200 million by 2030, highlighting the urgent need for effective treatment solutions.

Technological advancements and collaborations between healthcare providers and manufacturers also fuel market growth in the Asia Pacific region. In 2023, the Asia Pacific peritoneal dialysis market was valued at approximately $600 million, and it is projected to grow at a compound annual growth rate (CAGR) of over 10% through the next five years.

Global Peritoneal Dialysis Market: Segmentation Analysis

The Global Peritoneal Dialysis Market is segmented on the basis of By Treatment Type, By Product Type, By End User, and By Geography.

Global Peritoneal Dialysis Market, By Treatment Type

  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Based on Treatment Type, the Global Peritoneal Dialysis Market is segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Continuous Ambulatory Peritoneal Dialysis (CAPD) is the dominating segment due to its simplicity and the ability for patients to manage their treatments independently without the need for machines. However, Automated Peritoneal Dialysis (APD) is the fastest-growing segment, driven by advancements in technology and the increasing demand for more convenient and efficient treatment options.

Global Peritoneal Dialysis Market, By Product Type

  • Peritoneal Dialysis Solution Device
  • Peritoneal Dialysis Set
  • Catheter

Based on Product Type, the Global Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution Device, Peritoneal Dialysis Set and Catheter. The Peritoneal Dialysis Solution Device is the dominating segment due to its essential role in the dialysis process and the high demand for effective dialysis solutions. However, the Peritoneal Dialysis Set segment is the fastest-growing, driven by increasing adoption rates of home-based dialysis and advancements in technology that enhance user convenience and treatment efficacy.

Global Peritoneal Dialysis Market, By End User

  • Home-based Dialysis
  • Dialysis Center & Hospital-based Dialysis

Based on End User, the Global Peritoneal Dialysis Market is segmented into Home-based Dialysis and Dialysis Center & Hospital-based Dialysis. Home-based dialysis is the dominating segment due to its convenience and patient autonomy, allowing individuals to manage their treatment in the comfort of their homes. However, the fastest-growing segment is hospital-based dialysis, driven by advancements in technology, improved treatment options, and increasing awareness among healthcare providers about the benefits of in-center treatment for patients with complex medical needs.

Global Peritoneal Dialysis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Peritoneal Dialysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases.

Key Players

  • The "Global Peritoneal Dialysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
  • Fresenius Medical Care, Baxter International Inc., NxStage Medical Inc., DaVita Inc., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Braun Melsungen AG, Minntech Corporation, Maruho Co., Ltd., Terumo Corporation, Fresenius Kabi, Bellco Medical LLC, Vascular Solutions, Inc., Medtronic plc, Quanta Dialysis Technologies Ltd., Dialysis Clinic, Inc., US Renal Care, FMC Corporation, Amicus Therapeutics, Inc.
  • Our
  • market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
  • Global Peritoneal Dialysis Market: Recent Developments
  • In August 2024 Baxter International revealed plans to expand its manufacturing facilities for peritoneal dialysis products in response to increasing global demand. The expansion will enhance the company's production capacity and improve supply chain efficiency, allowing for quicker distribution of their innovative dialysis solutions.
  • In July 2024 Medtronic announced a collaboration with several digital health companies to integrate remote monitoring capabilities into its peritoneal dialysis devices. This partnership aims to enhance patient engagement and streamline treatment management through real-time data sharing between patients and healthcare providers.
  • In June 2024 Terumo Corporation unveiled new research initiatives focused on developing advanced peritoneal dialysis products that utilize biocompatible materials.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PERITONEAL DIALYSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PERITONEAL DIALYSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL PERITONEAL DIALYSIS MARKET, BY TREATMENT TYPE

  • 5.1 Overview
  • 5.2 Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • 5.3 Automated Peritoneal Dialysis (APD)

6 GLOBAL PERITONEAL DIALYSIS MARKET, BY PRODUCT TYPE

  • 6.1 Overview
  • 6.2 Peritoneal Dialysis Solution
  • 6.3 Device
  • 6.4 Peritoneal Dialysis Set
  • 6.5 Catheter
  • 6.6 Others

7 GLOBAL PERITONEAL DIALYSIS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Home-based Dialysis
  • 7.3 Dialysis Center & Hospital-based Dialysis

8 GLOBAL PERITONEAL DIALYSIS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL PERITONEAL DIALYSIS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Baxter International Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Fresenius Medical Care
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 NxStage Medical Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 DaVita Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Asahi Kasei Medical Co., Ltd.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Nipro Corporation
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 B. Braun Melsungen AG
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Minntech Corporation
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Maruho Co., Ltd.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Terumo Corporation
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research